Physician profile
Ryan K Lee
NPI 1811948144
$125,143.97
in general payments reported to CMS, 2019-2025
8 companies · $4,279 in 2025
The $4,279 reported for 2025 was more than what 94% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $6,938 · 2021: $6,764 · 2022: $41K · 2023: $45K · 2024: $1,038 · 2025: $4,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Travel and Lodging: $5,900 · Food and Beverage: $1,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,114.70 |
| Travel and Lodging | $5,900.44 |
| Food and Beverage | $1,631.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $77,489.94 | 2019-2023 | |
| Bayer Healthcare LLC | $36,812.73 | 2023-2025 | |
| Bracco Diagnostics INC. | $4,221.79 | 2019-2022 | |
| Philips North America LLC | $3,403.43 | 2020-2024 | (Bp3) Spectral Ct 7500, (O26) Sentinelle Coils |
| Guerbet LLC | $2,974.44 | 2025 | Elucirem |
| Aidoc Medical LTD | $181.00 | 2023-2024 | Briefcase |
| Ge Healthcare | $47.22 | 2024 | |
| Acerus Pharmaceuticals Corporation | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.